Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

Arcturus Therapeutics is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome. The most common available treatments for ADHD are stimulants that increase the brain chemicals dopamine and norepinephrine. Stimulants have significant side effects, and are classified as controlled substances which have significant potential for misuse, abuse and addiction. MDX is not a stimulant, and works with a different mechanism of action. MDX is a proprietary, combined rapid onset release formulation of the chemical Pyridoxine Pyroglutamate.

ArQule is a biopharmaceutical company engaged in the research and development of therapeutics to treat cancers and rare diseases. The company's clinical pipeline includes: ARQ 531, which is a reversible dual inhibitor of both wild type and C481S-mutant Bruton's tyrosine kinase for B-cell malignancies refractory to other therapeutic options; Miransertib, which is a selective inhibitor of protein kinase B (AKT) in combination with the hormonal therapy, anastrozole; ARQ 751, which is a selective inhibitor of AKT for solid tumors harboring AKT, phosphoinositide 3-kinase or phosphatase and tensin homolog (PTEN) mutations or that are PTEN null; and Derazantinib, which is a multi-kinase inhibitor.

Aduro Biotech is an immunotherapy company focused on the discovery, development and commercialization of therapies for the treatment of patients with diseases, including cancer. The company's primary technologies related to the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand pathways have a pipeline of clinical candidates including ADU-S100 (MIW815), ADU-S100 with spartalizumab, ADU-S100 with ipilimumab, ADU-S100 with anti-PD-1, cGAS-STING pathway inhibitor program, and BION-1301. The company's other programs consist of Anti-CD27 Antibody, which is a co-stimulatory receptor expressed on different immune cells, such as T-lymphocytes and NK cells.

Cognizant Technology Solutions is a services company, transforming customers' business, operating and technology models for the digital era. The company's services include digital services and solutions, consulting, application development, systems integration, application testing, application maintenance, infrastructure services and business process services. Additionally, the company develops, licenses, implements and supports proprietary and third-party software products and platforms. The company has organized its services and solutions into four practice areas: Digital Business, Digital Operations, Digital Systems and Technology and Consulting.

Contango Oil & Gas is an independent oil and natural gas company. The company's business is focused on the production from its offshore properties in the shallow waters of the Gulf of Mexico and onshore properties in Texas and Wyoming. The company is also engaged in the exploration, development, exploitation, production, and acquisition of crude oil and natural gas properties in West Texas, the onshore Texas Gulf Coast and the Rocky Mountain regions of the United States.

Fate Therapeutics is a biopharmaceutical company. The company's off-the-shelf, induced pluripotent stem cells (iPSC)-derived cellular immunotherapy pipeline include: FT500, which is an off-the-shelf natural killer (NK) cell cancer immunotherapy for the treatment of solid tumors; and FT516, which is an off-the-shelf NK cell cancer immunotherapy. The company's other iPSC-derived cell product candidates include: FT301, an off-the-shelf, immuno-regulatory cell product candidate derived from a clonal master iPSC line. The company's allogeneic cellular immunotherapy pipeline include: ProTmune?, an investigational programmed cellular immunotherapy for use as an allogeneic hematopoietic cell transplantation cell graft.

iRadimed develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services relating to them. The company provides products for sale: MRI compatible IV infusion pump system with associated disposable IV tubing sets; and 3880 MRI compatible patient vital signs monitoring system. The company's MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, proprietary single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, the company provides optional upgrade systems including the 3861 Side Car, 3865 Remote Display/Control, DERS and an SpO2 monitor.

Lexicon Pharmaceuticals is a biopharmaceutical company. The company is commercializing XERMELO? (telotristat ethyl), an orally-delivered small molecule drug for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. The company is developing Zynquista? (sotagliflozin), an orally-delivered small molecule drug candidate, as a treatment for type 1 2 diabetes. The company is also developing sotagliflozin as a treatment for type 2 diabetes, heart failure and chronic kidney disease. The company is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain.

PBF Energy is a holding company. Through its subsidiaries, the company is engaged as an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants and other petroleum products in the U.S. The company operates in two business segments: refining, which the company produces a variety of products at each of its refineries such as gasoline, ultra-low-sulfur diesel, heating oil, jet fuel, lubricants, petrochemicals and asphalt; and logistics, which through its PBF Logistics LP subsidiary, the company owns or leases, operates, develops and acquires crude oil and refined petroleum products terminals, pipelines, storage facilities and similar logistics assets.

PFSweb is a provider of omni-channel commerce solutions, including a range of technology, infrastructure and other services. The company's service offerings include website design, creation and integration, digital agency and marketing, eCommerce technologies, order management, customer care, logistics and fulfillment, financial management and consulting. The services the company provides are primarily organized into the following categories: Strategic Commerce Consulting Services; Design and Digital Marketing Services; Technology Services; Order to Cash; Fulfillment; and Customer Care.

Riverview Bancorp is a savings and loan holding company. Through its wholly-owned subsidiary, Riverview Community Bank (the Bank), the company is engaged primarily in the business of accepting deposits from the general public and using such funds, in its primary market area to originate commercial business, commercial real estate, multi-family real estate, land, real estate construction, residential real estate and other consumer loans. The Bank's subsidiary, Riverview Trust Company, is a trust and financial services company and provides brokerage activities, trust and asset management services.

Roadrunner Transportation Systems is an asset-right transportation and asset-light logistics service provider providing a suite of solutions under the Roadrunner, Active On-Demand and Ascent Global Logistics brands. The company has three segments: Truckload and Express Services, which provides air and ground expedite services, scheduled truckload services, intermodal services, temperature-controlled truckload services, and other truckload and logistics services; Less-than-Truckload (LTL), which involves the pickup, consolidation, linehaul, deconsolidation, and delivery of LTL shipments; and Ascent Global Logistics, which provides domestic freight management solutions.

Safestore Holdings is engaged in the rental of self-storage space and the sale of ancillary products such as insurance and merchandise (for example, packing materials and padlocks) in both the U.K. and Paris.

Tailored Brands is a retailer of men's tailored clothing and men's formalwear provider in the U.S. and Canada. The company's operations are conducted in two segments: retail, which provides the company's products and services primarily through the company's retail brands - Men's Wearhouse, Men's Wearhouse and Tux, Jos. A. Bank Clothiers, Moores, Joseph Abboud, and K&G - and the internet at www.menswearhouse.com, www.josbank.com, and www.josephabboud.com; and corporate apparel, which includes the activities from the company's corporate apparel and uniform operations conducted by Dimensions, Alexandra and Yaffy in the U.K. and Twin Hill in the U.S., which provide corporate apparel uniforms and workwear to workforces.

Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. The company's product categories are: biologics, which include Crysvita? (burosumab) for the treatment of X-linked hypophosphatemia and Mepsevii? (vestronidase alfa) for the treatment of Mucopolysaccharidosis VII; small molecules, which includes UX007 for the treatment of long-chain fatty acid oxidation disorders; and gene therapy, which includes DTX301 for the treatment of patients with ornithine transcarbamylase deficiency and DTX401 for the treatment of patients with glycogen storage disease type Ia.

WideOpenWesta is an integrated provider of high-speed data, cable television, digital telephony services to residential customers and provides a range of products and services to business customers. The company's products are available either as a bundle or as an individual service to residential and business service customers. In the Midwest, the company provides services in Detroit and Lansing, MI; Chicago, IL; Cleveland and Columbus, OH; Evansville, IN and Baltimore, MD. The Southeastern markets include Augusta, Columbus, Newnan and West Point, GA; Charleston, South Carolina; Dothan, Auburn, Huntsville and Montgomery, AL; Knoxville, TN; and Panama City and Pinellas County, FL.

Zuora is a cloud-based subscription management platform. The company's solution is the system of record for its customers' subscription business models and consists of three components: the company's Zuora Central Platform, which platform acts as an intelligent subscription management hub, allowing customers to orient operations around it to create a process designed for subscription business models; other products, which consists of Zuora Billing and Zuora RevPro; and an application marketplace, which the Zuora Marketplace provides industry-specific tools and third-party applications that extend the company's capabilities for its customers.